본문으로 건너뛰기
← 뒤로

Ultrasound-targeted microbubble destruction enhances RSL3-induced ferroptosis in anaplastic thyroid carcinoma.

2/5 보강
iScience 📖 저널 OA 100% 2023: 4/4 OA 2024: 21/21 OA 2025: 69/69 OA 2026: 112/112 OA 2023~2026 2026 Vol.29(3) p. 114993 OA Ferroptosis and cancer prognosis
TL;DR UTMD-mediated RSL3 delivery is supported as an effective approach to enhance ferroptosis-based therapy for ATC, and the combination of RSL3-MBs with UTMD significantly inhibited the growth of ATC without evident systemic toxicity.
Retraction 확인
출처
PubMed DOI PMC OpenAlex Semantic 마지막 보강 2026-05-02
OpenAlex 토픽 · Ferroptosis and cancer prognosis Thyroid Cancer Diagnosis and Treatment Protease and Inhibitor Mechanisms

Liu X, Wang L, Liu X, Du Y, Zhang B

📝 환자 설명용 한 줄

UTMD-mediated RSL3 delivery is supported as an effective approach to enhance ferroptosis-based therapy for ATC, and the combination of RSL3-MBs with UTMD significantly inhibited the growth of ATC with

이 논문을 인용하기

↓ .bib ↓ .ris
APA Xinyao Liu, Liangkai Wang, et al. (2026). Ultrasound-targeted microbubble destruction enhances RSL3-induced ferroptosis in anaplastic thyroid carcinoma.. iScience, 29(3), 114993. https://doi.org/10.1016/j.isci.2026.114993
MLA Xinyao Liu, et al.. "Ultrasound-targeted microbubble destruction enhances RSL3-induced ferroptosis in anaplastic thyroid carcinoma.." iScience, vol. 29, no. 3, 2026, pp. 114993.
PMID 41782831 ↗

Abstract

Anaplastic thyroid carcinoma (ATC) is a highly aggressive malignancy with limited effective therapies. Ferroptosis, a form of programmed cell death, is closely associated with thyroid cancer prognosis and represents a potential therapeutic target. This study evaluated the antitumor effects of ultrasound-targeted microbubble (MB) destruction (UTMD)-mediated RAS-selective lethal 3 (RSL3) delivery to induce ferroptosis in ATC. MBs loaded with ferroptosis inducer RSL3 were synthesized and intravenously administered in a nude mouse ATC model, followed by localized ultrasound irradiation to enable targeted intratumoral drug release. RSL3-MBs exhibited uniform particle size, good biocompatibility, and excellent contrast performance. The combination of RSL3-MBs with UTMD significantly inhibited the growth of ATC without evident systemic toxicity. This strategy was shown to be more effective than the delivery methods involving either RSL3 solution or RSL3-MBs alone. These findings support UTMD-mediated RSL3 delivery as an effective approach to enhance ferroptosis-based therapy for ATC.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기